The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARalpha-tr, autonomously regulates proliferative and pro-inflammatory genes


BACKGROUND: The peroxisome proliferator-activated receptor alpha (PPARalpha) controls lipid/energy homeostasis and inflammatory responses. The truncated splice variant PPARalpha-tr was suggested to exert a dominant negative function despite being unable to bind consensus PPARalpha DNA response elements. METHODS: The distribution and variability factor of each PPARalpha variant were assessed in the well-characterized cohort of human liver samples (N = 150) on the mRNA and protein levels. Specific siRNA-mediated downregulation of each transcript as well as specific overexpression with subsequent qRT-PCR analysis of downstream genes was used for investigation of specific functional roles of PPARalpha-wt and PPARalpha-tr forms in primary human hepatocytes. RESULTS: Bioinformatic analyses of genome-wide liver expression profiling data suggested a possible role of PPARalpha-tr in downregulating proliferative and pro-inflammatory genes. Specific gene silencing of both forms in primary human hepatocytes showed that induction of metabolic PPARalpha-target genes by agonist WY14,643 was prevented by PPARalpha-wt knock-down but neither prevented nor augmented by PPARalpha-tr knock-down. WY14,643 treatment did not induce proliferative genes including MYC, CDK1, and PCNA, and knock-down of PPARalpha-wt had no effect, while PPARalpha-tr knock-down caused up to 3-fold induction of these genes. Similarly, induction of pro-inflammatory genes IL1B, PTGS2, and CCL2 by IL-6 was augmented by knock-down of PPARalpha-tr but not of PPARalpha-wt. In contrast to human proliferative genes, orthologous mouse genes were readily inducible by WY14,643 in PPARalpha-tr non-expressing AML12 mouse hepatocytes. Induction was augmented by overexpression of PPARalpha-wt and attenuated by overexpression of PPARalpha-tr. Pro-inflammatory genes including IL-1beta, CCL2 and TNFalpha were induced by WY14,643 in mouse and human cells and both PPARalpha forms attenuated induction. As potential mechanism of PPARalpha-tr inhibitory action we suggest crosstalk with WNT/beta-catenin pathway. Finally, treatment with WY14,643 in the presence of PPARalpha-tr resulted in the significant reduction of cell viability of AML12 and human ovarian cancer cell line, SKOV3. CONCLUSIONS: Our data suggest that the truncated PPARalpha splice variant functions as an endogenous inhibitor of proliferative and pro-inflammatory genes in human cells and that its absence in mouse may explain species-specific differences in fibrate-induced hepatocarcinogenesis.


Projects: A3.4: Linking signalling to metabolic functions, B5: Cell-cell communication influences detoxifying functions in hepatocytes

BMC Cancer
BMC Cancer. 2015 Jun 30;15:488. doi: 10.1186/s12885-015-1500-x.
30th Jun 2015

M. Thomas, C. Bayha, K. Klein, S. Muller, T. S. Weiss, M. Schwab, U. M. Zanger

help Authors

[Maria Thomas] [Kathrin Klein] [Thomas Weiss] [Matthias Schwab] [Ulrich Zanger]

help Attributions


help Scales

Not Specified
Views: 1341
  • Created: 17th Sep 2015 at 10:19

Related items


Log in / Register

Need an account?
Sign up

Forgotten password?

Front Page

Virtual Liver Network


Related Projects and friends

Imprint Taverna workflow workbench myExperiment JWS Online ISATAB myGrid Sabio-RK BioPortal Semantic SBML

Powered by:


Silk icons 1.3
Crystal Clear icons

Virtual Liver Seek uses one essential cookie to keep you session open and one cookie to keep your consent.

By continuing to use this site you agree to the use of cookies